COMMUNIQUÉS West-GlobeNewswire

TG Therapeutics to Present at the Raymond James Life Sciences and MedTech Conference
18/06/2019
Presentation scheduled for tomorrow, Wednesday, June 19, 2019, at 9:10 AM ET NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s [...]
SIGA Technologies CEO to Speak at NCT Europe on June 27, 2019
18/06/2019
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez, [...]
Helius Medical Technologies, Inc. Provides a Business Update on FDA Strategy
18/06/2019
NEWTOWN, Pa., June 18, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today is providing an update [...]
AGTC to Present at BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference on June 25, 2019
18/06/2019
GAINESVILLE, Fla., and CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
ONL Therapeutics Names Industry Veteran as CEO as Company Prepares for First in Human Clinical Trials
18/06/2019
David A. Esposito Appointed President and Chief Executive Officer as Company Accelerates Preparation of ONL1204 for Retinal Detachment Clinical Trial ANN ARBOR, Mich., June 18, 2019 (GLOBE NEWSWIRE) -- ONL Therapeutics [...]
Increased BARDA Award and Option Exercise
18/06/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Announces BARDA Increases Award for Ridinilazole Clinical and Regulatory Development to up to $63.7 Million and Exercises Next Contract Option Summit Awarded $9 [...]
Amarin to Present at the 2019 BMO Prescription For Success Healthcare Conference
18/06/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, June 18, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
BeiGene and SpringWorks Therapeutics Announce the Formation of MapKure to Develop BGB-3245, an Investigational, Selective Next-Generation RAF Kinase Inhibitor
18/06/2019
CAMBRIDGE, Mass. and BEIJING, China and STAMFORD, Conn., June 18, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing [...]
Media Advisory: Canadian Blood Services board meeting open to the public
18/06/2019
TORONTO, June 18, 2019 (GLOBE NEWSWIRE) -- On June 20, Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at blood.ca, and inviting the public to attend in [...]
Avis aux médias : Le conseil d’administration de la Société canadienne du sang ouvre sa prochaine réunion au public
18/06/2019
TORONTO, 18 juin 2019 (GLOBE NEWSWIRE) -- La Société canadienne du sang invite la population à assister, en personne ou en ligne, à la réunion du conseil d’administration qui aura lieu à Toronto. La réunion sera [...]
Precision Biomonitoring and Birks Natural Heritage Consultants Announce Strategic Partnership Advancing Adoption of Environmental DNA Methods
18/06/2019
GUELPH, Ontario and BARRIE, Ontario, June 18, 2019 (GLOBE NEWSWIRE) -- Precision Biomonitoring Inc. , a leader in environmental DNA (eDNA) detection of organisms, and Birks Natural Heritage Consultants, Inc. , a full- [...]
YSS Corp. Announces Receipt of Cannabis Retail License for Additional Calgary Location
18/06/2019
CALGARY, Alberta, June 18, 2019 (GLOBE NEWSWIRE) -- YSS Corp.™ (the “ Company ” or “ YSS ”) (TSXV: YSS) (WKN: A2PMAX) is pleased to announce that the Company has received a cannabis retail license from the Alberta [...]
MediPharm Labs Announces Application to Upgrade Listing to the Toronto Stock Exchange
18/06/2019
TORONTO, June 18, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
Tetra Bio-Pharma’s Management Provides Corporate Update Ahead of Annual General Meeting
18/06/2019
U.S. granted patent protection for ophthalmic use; U.S. granted patent protection for topical delivery, increased drug solubility and abuse deterrence; U.S. FDA provides positive response on painful dry eye development [...]
Transactions in relation to share buyback program
18/06/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
G1 Therapeutics Announces Updated Results from Phase 2 Trial of Trilaciclib in Combination with Chemotherapy Showed Statistically Significant Improvement in Overall Survival in Women with Metastatic Triple-Negative Breast Cancer
18/06/2019
- Detailed data from this trial will be presented at a medical meeting later this year - RESEARCH TRIANGLE PARK, N.C., June 18, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology [...]
Zosano Pharma Completes Site Qualification Batches at Contract Manufacturing Organization as it Prepares for NDA Submission of Qtrypta™
18/06/2019
Technical Transfer of manufacturing process to CMO signals commencement of commercial readiness activities NDA planned for Q4 2019 FREMONT, Calif., June 18, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: [...]
High Economic Burden in Children With Steroid Refractory Acute Graft Versus Host Disease
18/06/2019
Mesoblast Presents Health Economics and Outcomes R esearch Data at 24 th European Hematology Association Congress MELBOURNE, Australia; and NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; Nasdaq [...]
Leading Austrian Clinic, Klinik Pirawarth, Provides Positive Feedback on its First Nexstim NBT® System for Treatment of Depression and Pain
18/06/2019
Press Release, Helsinki, 18 June 2019 at 1.00 pm (EET) Leading Austrian Clinic, Klinik Pirawarth, Provides Positive Feedback on its First Nexstim NBT® System for Treatment of Depression and Pain Nexstim Plc (NXTMH:HEX, [...]

Pages